Sat, May 25, 2013, 11:23 AM EDT - U.S. Markets closed
you are viewing a single comment's thread.
"SNY" has spent $17 billion for 25 small bio-tech companies in the last two years. Biodel fits the profile of the acquired companies perfectly. Average price tag:$685,000,000
BIOD will NEVER be sold for under $1B.
With viaject approval $1B + yes.